Amyotrophic lateral sclerosis

EL Feldman, SA Goutman, S Petri, L Mazzini… - The Lancet, 2022 - thelancet.com
Amyotrophic lateral sclerosis is a fatal CNS neurodegenerative disease. Despite intensive
research, current management of amyotrophic lateral sclerosis remains suboptimal from …

Emerging insights into the complex genetics and pathophysiology of amyotrophic lateral sclerosis

SA Goutman, O Hardiman, A Al-Chalabi… - The Lancet …, 2022 - thelancet.com
Amyotrophic lateral sclerosis is a fatal neurodegenerative disease. The discovery of genes
associated with amyotrophic lateral sclerosis, commencing with SOD1 in 1993, started fairly …

The amyotrophic lateral sclerosis exposome: recent advances and future directions

SA Goutman, MG Savelieff, DG Jang, J Hur… - Nature Reviews …, 2023 - nature.com
Amyotrophic lateral sclerosis (ALS) is a fatal disease of motor neuron degeneration with
typical survival of only 2–5 years from diagnosis. The causes of ALS are multifactorial …

Sex difference in human diseases: mechanistic insights and clinical implications

Y Shi, J Ma, S Li, C Liu, Y Liu, J Chen, N Liu… - Signal transduction and …, 2024 - nature.com
Sex characteristics exhibit significant disparities in various human diseases, including
prevalent cardiovascular diseases, cancers, metabolic disorders, autoimmune diseases …

Motor band sign in motor neuron diseases using magnetic resonance imaging: a systematic review

S Mohammadi, S Ghaderi - Acta Neurologica Scandinavica, 2023 - Wiley Online Library
Motor neuron diseases (MNDs) like amyotrophic lateral sclerosis (ALS) are progressive
neurodegenerative disorders affecting upper and lower motor neurons (UMN and LMN) …

Wearable device and smartphone data quantify ALS progression and may provide novel outcome measures

SA Johnson, M Karas, KM Burke, M Straczkiewicz… - NPJ Digital …, 2023 - nature.com
Amyotrophic lateral sclerosis (ALS) therapeutic development has largely relied on staff-
administered functional rating scales to determine treatment efficacy. We sought to …

Recent progress of the genetics of amyotrophic lateral sclerosis and challenges of gene therapy

H Wang, LP Guan, M Deng - Frontiers in neuroscience, 2023 - frontiersin.org
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder characterized by the
degeneration of motor neurons in the brain and spinal cord. The causes of ALS are not fully …

Sex and gender differences in Alzheimer's disease, Parkinson's disease, and Amyotrophic Lateral Sclerosis: A narrative review

A Nicoletti, R Baschi, CE Cicero, S Iacono… - Mechanisms of ageing …, 2023 - Elsevier
Abstract Neurodegenerative diseases (NDs), including Alzheimer's disease (AD),
Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS), exhibit high phenotypic …

Deciphering lipid dysregulation in ALS: from mechanisms to translational medicine

I Agrawal, YS Lim, SY Ng, SC Ling - Translational Neurodegeneration, 2022 - Springer
Lipids, defined by low solubility in water and high solubility in nonpolar solvents, can be
classified into fatty acids, glycerolipids, glycerophospholipids, sphingolipids, and sterols …

Neurofilaments as biomarkers in neurological disorders—towards clinical application

M Khalil, CE Teunissen, S Lehmann, M Otto… - Nature Reviews …, 2024 - nature.com
Neurofilament proteins have been validated as specific body fluid biomarkers of neuro-
axonal injury. The advent of highly sensitive analytical platforms that enable reliable …